Learning Modules – SCAN-ECHO
SCAN-ECHO (Specialty Care Access Network-Extension of Community Healthcare Outcomes) is a specialty care transformative initiative from the Office of Specialty Care Services, Department of Veterans Affairs.
Our faculty, in collaboration with the Veterans Affairs Ann Arbor Healthcare System SCAN-ECHO Liver Program, has made a series of learning modules for health providers.
- Alcoholic hepatitis: Diagnosis and management
Grace L. Su, MD - Approach to the patient with abnormal liver tests: Part I
Richard H. Moseley, MD - Approach to the patient with abnormal liver tests: Part II
Richard H. Moseley, MD - Approach to the patient with cirrhosis: A primer for primary care providers
Grace L. Su, MD - Approach to patients with HCV/HIV coinfection
Sandro Cinti, MD - Autoimmune liver disease
Grace L. Su, MD - Chronic hepatitis C virus: Treatment of genotype 2/3 infection
Andrew Tai, MD, PhD - Chronic hepatitis C virus infection: Epidemiology and natural history
Andrew Tai, MD, PhD - Diagnosis and management of cirrhotic ascites
Rebecca Van Dyke, MD - Diagnosis and management of esophageal varices
Robert J. Fontana, MD - Evaluation of a liver mass
Jorge A. Marrero, MD, MS - Hematological abnormalities in cirrhosis
Rebecca Van Dyke, MD - Hepatic encephalopathy: An update for primary care physicians
Michael L. Volk, MD, MSc - Hepatitis B assays
Anna S.F. Lok, MD - Hepatitis C Virus Webinar Part 2: HCV Treatment
Ponni Perumalswami, MD - Hepatitis C Screening and Epidemiology
Ponni Perumalswami, MD - Hereditary liver diseases
Rebecca Van Dyke, MD - Liver Biopsy
Andrew Tai, MD, PhD - Liver transplantation: Why, when, and how: Part I
Grace L. Su, MD - Managing dermatologic side effects of HCV antiviral therapy
Heather McCurdy, BSN, RN - Management of chronic HBV infection
Anna S.F. Lok, MD - Medical care of the post liver transplant patient from a primary care perspective: Part I
Grace L. Su, MD - MOC Hepatitis C Webinar Series
Ponni Perumalswami, MD - Non-alcoholic fatty liver disease diagnosis
Hari S. Conjeevaram, MD, MSc - Non-alcoholic fatty liver disease management
Hari S. Conjeevaram, MD, MSc - Optimizing renal function in cirrhosis: An act of balancing
Pratima Sharma, MD, MS - Pain management in patients with liver disease
Mina Rakoski, MD, MSc - Paracentesis
Dave Bialy, PA-C, Grace L. Su, MD, Andrew Tai, MD, PhD - Treatment of hepatocellular carcinoma
Jorge A. Marrero, MD, MS - Statins and liver disease
Richard H. Moseley, MD - Surveillance and diagnosis of hepatocellular carcinoma
Jorge A. Marrero, MD, MS - Treatment of chronic HCV infection: Management of hematologic side effects
Andrew Tai, MD, PhD
Tools
Renal Risk Index (RRI) Calculator
Renal Risk Index (RRI) describes the continuum of risk of End Stage Renal Disease (ESRD) after liver transplantation. It is applicable to all liver transplant recipients age ≥ 18 years. This calculator can be used to compute the RRI, the RRI decile (range), and the cumulative incidence of post–liver transplant ESRD corresponding to the decile for a hypothetical or actual liver transplant recipient. Click here.
